2.21
In 8 Bio Inc stock is traded at $2.21, with a volume of 20,065.
It is down -2.21% in the last 24 hours and up +0.45% over the past month.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
See More
Previous Close:
$2.26
Open:
$2.26
24h Volume:
20,065
Relative Volume:
0.11
Market Cap:
$10.03M
Revenue:
-
Net Income/Loss:
$-31.88M
P/E Ratio:
-2.9467
EPS:
-0.75
Net Cash Flow:
$-25.20M
1W Performance:
-2.21%
1M Performance:
+0.45%
6M Performance:
-70.93%
1Y Performance:
-85.81%
In 8 Bio Inc Stock (INAB) Company Profile
Name
In 8 Bio Inc
Sector
Industry
Phone
(646) 600-6438
Address
EMPIRE STATE BUILDING, NEW YORK
Compare INAB with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
INAB
In 8 Bio Inc
|
2.21 | 10.26M | 0 | -31.88M | -25.20M | -0.75 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
In 8 Bio Inc Stock (INAB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-18-24 | Initiated | Laidlaw | Buy |
Aug-30-22 | Initiated | H.C. Wainwright | Buy |
In 8 Bio Inc Stock (INAB) Latest News
Signal strength of KALA BIO Inc. stock in tech scannersJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Historical volatility pattern of GRI Bio Inc. visualizedDay Trade & Fast Momentum Entry Tips - Newser
Will a bounce in Instil Bio Inc. offer an exit2025 Biggest Moves & AI Powered Buy and Sell Recommendations - Newser
TELA Bio Inc. stock momentum explainedJuly 2025 Patterns & Stock Market Timing Techniques - Newser
Understanding Instil Bio Inc.’s price movementMarket Growth Review & Safe Swing Trade Setups - Newser
Regression analysis insights on GRI Bio Inc. performanceJuly 2025 Review & Fast Gaining Stock Reports - Newser
How to forecast Passage Bio Inc. trends using time series2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
Smart tools for monitoring KALA BIO Inc.’s price actionAnalyst Upgrade & Proven Capital Preservation Tips - Newser
PAH Drug Developer Gossamer Bio Set for Key Presentations at Cantor, Wells Fargo, HC Wainwright Events - Stock Titan
Layoff Tracker: Exelixis Cuts Go Beyond Pennsylvania, Include 71 at California HQ - BioSpace
Is Nuvation Bio Inc. stock poised for growthJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Is Palisade Bio Inc. trending in predictive chart modelsJuly 2025 Momentum & Low Drawdown Momentum Trade Ideas - Newser
Trend analysis for Adicet Bio Inc. this weekBull Run & Stock Timing and Entry Methods - Newser
What candlestick patterns are forming on bluebird bio Inc.Stop Loss & Free AI Powered Buy and Sell Recommendations - Newser
What’s next for INmune Bio Inc. stock priceWeekly Trade Review & Entry Point Confirmation Signals - Newser
Genetic Medicines Pioneer Passage Bio to Showcase Neurodegenerative Disease Pipeline at Global Conference - Stock Titan
Visualizing Third Harmonic Bio Inc. stock with heatmaps2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Global Oncology Company Nuvation Bio Announces Triple Conference Schedule for September 2025 - Stock Titan
Is now a turning point for Adicet Bio Inc.Weekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Clinical-Stage Biotech Belite Bio Secures Speaking Slots at Three Premier Healthcare Conferences - Stock Titan
Live market analysis of Third Harmonic Bio Inc.2025 Market Trends & Scalable Portfolio Growth Methods - Newser
H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB) - MSN
Combining price and volume data for Nuvation Bio Inc.Dip Buying & Safe Swing Trade Setups - Newser
GRI Bio Inc. stock prediction for this weekQuarterly Trade Report & Daily Stock Trend Reports - Newser
Is Palisade Bio Inc. stock ready for a breakoutBear Alert & Low Drawdown Momentum Trade Ideas - Newser
Stop Loss: Is Upstream Bio Inc. forming a double bottomJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - theviewers.co.kr
Mustang Bio Inc. stock trend forecastJuly 2025 Summary & Verified Momentum Watchlists - Newser
Volume spikes in Palisade Bio Inc. stock – what they meanWeekly Market Outlook & Precise Swing Trade Alerts - Newser
Using economic indicators to assess Cabaletta Bio Inc. potentialWeekly Market Outlook & Low Volatility Stock Suggestions - Newser
Is Third Harmonic Bio Inc. building a consolidation baseJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Heatmap analysis for Gossamer Bio Inc. and competitorsMarket Movers & Fast Exit Strategy with Risk Control - Newser
Combining price and volume data for Kronos Bio Inc.Rate Hike & Fast Momentum Stock Entry Tips - Newser
Regression analysis insights on Gossamer Bio Inc. performanceBreakout Watch & High Return Trade Guides - Newser
Sentiment Tools Show Shift in Trader Mood on Cabaletta Bio Inc.2025 Sector Review & Community Driven Trade Alerts - beatles.ru
Gossamer Bio Inc.’s Beta Climbs After Market VolatilityJuly 2025 Summary & High Yield Stock Recommendations - classian.co.kr
GRI Bio CEO to Showcase NKT Cell Therapy Pipeline at Webull Biotech Investor Event - Stock Titan
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Infinity Bio, Inc. Partners With the Austrian Institute of Technology to Provide Access to Antibody Reactome Profiling in Europe - Business Wire
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire
Is Tourmaline Bio Inc. stock ready for a breakoutFree Alpha Driven Watchlist With Alerts - Newser
Belite Bio Inc expected to post a loss of 42 cents a shareEarnings Preview - TradingView
Korro Bio Inc expected to post a loss of $2.56 a shareEarnings Preview - TradingView
Annovis Bio Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
MUSTANG BIO, INC. SEC 10-Q Report - TradingView
REPEATTevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions - uk.finance.yahoo.com
KALA BIO Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Instil Bio Inc expected to post a loss of $2.50 a shareEarnings Preview - TradingView
KALA BIO, Inc. SEC 10-Q Report - TradingView
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts - The Globe and Mail
INmune Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
In 8 Bio Inc Stock (INAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):